1. Angiotensin II Type 2 Receptor Vasoactivity in Internal Mammary Arteries of Patients With Coronary Artery Disease
- Author
-
R. M. A van de Wal, H.W.M. Plokker, Georg Nickenig, W. J. Morshuis, D. J. Van Veldhuisen, W. H. Van Gilst, P. van der Harst, Hendrik Buikema, Lodewijk J. Wagenaar, Sven Wassmann, and A. A. Voors
- Subjects
Male ,Angiotensin receptor ,Pyridines ,Vasodilator Agents ,Gene Expression ,Tetrazoles ,Vasodilation ,Coronary Artery Disease ,Phenylephrine ,Vasoconstrictor Agents ,Receptor ,Mesenteric arteries ,Aged, 80 and over ,Angiotensin II ,Imidazoles ,Middle Aged ,Receptor antagonist ,medicine.anatomical_structure ,cardiovascular system ,Female ,Cardiology and Cardiovascular Medicine ,Oligopeptides ,hormones, hormone substitutes, and hormone antagonists ,medicine.drug ,Adult ,medicine.medical_specialty ,medicine.drug_class ,In Vitro Techniques ,Receptor, Angiotensin, Type 2 ,Receptor, Angiotensin, Type 1 ,Internal medicine ,medicine ,Humans ,Mammary Arteries ,Phentolamine ,Adrenergic alpha-Antagonists ,Aged ,Pharmacology ,Angiotensin II receptor type 1 ,Sodium Nitrite ,business.industry ,Biphenyl Compounds ,Acetylcholine ,Candesartan ,Endocrinology ,Benzimidazoles ,business ,Angiotensin II Type 1 Receptor Blockers - Abstract
Background: Several animal studies suggested that the angiotensin II type 2 (AT2) receptor subtype mediates vasodilation, yet the results in human arteries are less well described and more inconsistent. Therefore, we evaluated the role of the AT2 receptor stimulation on the vasotonus of human internal mammary arteries. Methods: Internal mammary arteries were obtained from 50 patients undergoing coronary bypass surgery. The expression of angiotensin II type I (AT1) receptor and AT2 receptor mRNA was determined by using real-time polymerase chain reaction. In addition, angiotensin II and CGP42112A concentration-response curves (concentration range: 10(-10) M to 10(-6) M) were constructed in absence or presence of candesartan (10(-5) M) and/or the AT2 receptor-antagonist PD-123319 (10-6 M) and/or the a receptor antagonist phentolamine. Results: Both AT1 and AT2 receptor protein and mRNA were detected, and higher AT2 receptor mRNA expression levels were associated with increased contractile response to angiotensin II. Angiotensin II caused vasoconstriction up to 41.1 +/- 6.5% of the maximal response to phenylephrine, and PD123319 significantly reduced this response (28.6 +/- 9.6%, P
- Published
- 2007
- Full Text
- View/download PDF